Success

Alert

Please select a Day.

Info

Hikal Ltd.

Sector : Healthcare | Industry : Pharmaceuticals & Drugs

Have a query? Talk to Experts LIVE

Follow Following

Score

42/100

252.89

8.72 (3.57%)

As on 04 Dec, 2025 | 03:57

Open Trading A/c

Day Range

242.00

261.00

L H

52 Week Range

218.00

456.75

L H

Volume

20,201,986

* BSE Market Depth (04 Dec 2025)

BUY		SELL
QTY	PRICE	PRICE	QTY
222	253.20	253.70	19
563	252.90	254.95	222
240	252.85	255.30	118
600	252.10	256.00	951
1500	252.05	256.20	1
0	Total	Total	0

Bid / Ask

0.00 / 0.00

Advance Chart

Score

42/100

253.20

9.45 (3.88%)

As on 04 Dec, 2025 | 04:01

Open Trading A/c

Day Range

242.45

260.80

L H

52 Week Range

217.35

456.60

L H

Volume

2,547,585

* BSE Market Depth (04 Dec 2025)

BUY		SELL
QTY	PRICE	PRICE	QTY
222	253.20	253.70	19
563	252.90	254.95	222
240	252.85	255.30	118
600	252.10	256.00	951
1500	252.05	256.20	1
0	Total	Total	0

Bid / Ask

0.00 / 0.00

Advance Chart

Hikal

252.89

8.72(3.57%)

NSE

#KnowBeforeYouInvest
Forecast

MC Essentials

47% Pass

MC Technicals

This represents current trend.Click here for disclaimer.

Trend

MC Insights

Superior Financial Strength, Low Growth Trend Stock at Reasonable Valuations

Financials

Ownerships

Industry Comparison

Others

Overview
Chart
Forecast
MC Insights
MC Technicals
Scans
Price & Volume
Seasonality Analysis
News
Forum
Research
Deals
Corp Action
Financials
Shareholding
Financials Shareholding Peers About

Open	248.49
Previous Close	244.17
Volume	20,201,986.00
Value (Lacs)	51,088.80
VWAP	250.88
Beta	0.81 0.72
Mkt Cap (Rs. Cr.)	3,118

High	261.00
Low	242.00
UC Limit	293.00
LC Limit	195.33
52 Week High	456.75
52 Week Low	218.00
Face Value	2.00

All Time High	742.00
All Time Low	6.36
20D Avg Volume	2,397,915
20D Avg Delivery(%)	7.64
Book Value Per Share	102.37
Dividend Yield	0.55

TTM EPS See historical trend	0.82 (-86.22% YoY)
TTM PE See historical trend	308.40 (High PE)
P/B See historical trend	2.48 (Low P/B)
Sector PE	40.08

Advanced Chart

Click here to expand

*Delayed by 20 seconds.

Forecast

Share Price Forecast

Earnings Forecast

Actuals Estimates

ANNUALLY

(Rs.)

EPS
Net Profit
Revenue

Valuations

Consensus Recommendations

Buy
Outperform
Hold
Underperform
Sell

Hits/Misses

QUARTERLY (Rs.)

EPS
Net Profit
Revenue

# of Beats

# of Misses

# of Inline

# of Beats

# of Misses

# of Inline

# of Beats

# of Misses

# of Inline

MC Insights

Stock Score

42/100

Superior Financial Strength, Low Growth Trend Stock at Reasonable Valuations

Get detailed analysis with Moneycontrol Stock Insights.

Price

44.63% away from 52 week high

Financials

Piotroski Score

indicates

Industry Comparison

Market Cap - Above Median

Shareholding Pattern

Promoter holding remains unchanged at 68.85% in Sep 2025 qtr.

MC Technicals

TECHNICAL RATING

This represents current trend.
Click here for disclaimer.

Trend

See Detail

Historical Rating

Moving Averages	--
Technical Indicators	--
Moving Averages Crossovers	--

Pivot levels

Type	R1	R2	R3	PP	S1	S2	S3
Classic	- -	- -	- -	- -	- -	- -	- -
Fibonacci	- -	- -	- -	- -	- -	- -	- -
Camarilla	- -	- -	- -	- -	- -	- -	- -

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels

R1	- -	Pivot - -	S1	- -
R2	- -		S2	- -
R3	- -		S3	- -

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Moving Averages

Days
5	- -
10	- -
20	- -
50	- -
100	- -
200	- -

TECHNICAL RATING

This represents current trend.
Click here for disclaimer.

Trend

See Detail

Historical Rating

Moving Averages	--
Technical Indicators	--
Moving Averages Crossovers	--

Pivot levels

Type	R1	R2	R3	PP	S1	S2	S3
Classic	- -	- -	- -	- -	- -	- -	- -
Fibonacci	- -	- -	- -	- -	- -	- -	- -
Camarilla	- -	- -	- -	- -	- -	- -	- -

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels

R1	- -	Pivot - -	S1	- -
R2	- -		S2	- -
R3	- -		S3	- -

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Moving Averages

Days

TECHNICAL RATING

This represents current trend.
Click here for disclaimer.

Trend

See Detail

Historical Rating

Moving Averages	--
Technical Indicators	--
Moving Averages Crossovers	--

Pivot levels

Type	R1	R2	R3	PP	S1	S2	S3
Classic	- -	- -	- -	- -	- -	- -	- -
Fibonacci	- -	- -	- -	- -	- -	- -	- -
Camarilla	- -	- -	- -	- -	- -	- -	- -

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Pivot levels

R1	- -	Pivot - -	S1	- -
R2	- -		S2	- -
R3	- -		S3	- -

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Moving Averages

Days

Price and Volume

Price Performance

1 Week		--%
1 Month		--%
3 Months		--%
YTD		--%
1 Year		--%
3 Years		--%

Volume Analysis

Volume
Delivery

SEASONALITY ANALYSIS

10 out of 17 years Hikal has given positive returns in December.

Month	Max. Positive Change(%)	Avg. Positive Change(%)	Max. Negative Change(%)	Avg. Negative Change(%)	Average Change(%)
December	25.86% (2015)	9.70%	-6.74% (2016)	-3.73%	4.17%

Seasonality Analysis

News

Hikal Consolidated September 2025 Net Sales at Rs 318.50 crore, down 29.68% Y-o-Y

Nov 26 2025 03:02 PM

Hikal Standalone September 2025 Net Sales at Rs 318.50 crore, down 29.68% Y-o-Y Nov 20 2025 02:22 PM
Stocks to Watch Today: Hindustan Unilever, Wipro, Apollo Hospitals, Hikal, GHV Infra, Texmaco Rail, Vedanta, Titagarh Rail, R Systems in focus on 22 August Aug 22 2025 02:52 AM
Hikal Standalone June 2025 Net Sales at Rs 380.40 crore, down 6.49% Y-o-Y Aug 21 2025 03:20 PM
Hikal Q1 FY26: Net Loss at u20b923 Crore, Revenue Declines 6.5% YoY Aug 07 2025 04:53 PM

Earning + See More

Forum

Community Sentiments

100% BUY
0% SELL
0% HOLD

100%

of moneycontrol users recommend buying Hikal

What's your call on Hikal today?

Read 3 investor views

BUY SELL HOLD

sarav
Hikal
Follow

6 hrs ago

worthless stock . no end in sight for their woes. View more

Posted by : sarav
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  worthless stock . no end in sight for their woes.
  
  Repost Cancel
You will now receive notification when someone reply to this message.
InvSmrt
Hikal
Follow

20 hrs ago

ups and downs are investors nightmare but speculators and chartists delight View more

Posted by : InvSmrt
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  ups and downs are investors nightmare but speculators and chartists delight
  
  Repost Cancel
You will now receive notification when someone reply to this message.
The Fixed Income
Bonds
Follow

8 hrs ago

Sponsored Post
Lock in a Steady 9.15% from a Trusted NBFC Bond 9.15% VIVRITI CAPITAL LIMITED 2027 ✔️ Coupon: 9.15% ✔️ Rating: CARE A+ Stable ✔️ Tenor: 1y 10m (Maturity: 04 Nov 2027) Senior Secured | High-Return | NBFC Bond | Listed Add a reliable, secured NBFC bond to your portfolio and benefit from consistent yields with medium-term tenure. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJDc1lRPT0=/1060-navi-finserv-limited-2027?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list View more

Posted by : The Fixed Income
- Like
- Reply
  
  reply Cancel
- Share
  
  276
- Repost
  
  Repost this message
  
  Lock in a Steady 9.15% from a Trusted NBFC Bond 9.15% VIVRITI CAPITAL LIMITED 2027 ✔️ Coupon: 9.15% ✔️ Rating: CARE A+ Stable ✔️ Tenor: 1y 10m (Maturity: 04 Nov 2027) Senior Secured | High-Return | NBFC Bond | Listed Add a reliable, secured NBFC bond to your portfolio and benefit from consistent yields with medium-term tenure. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJDc1lRPT0=/1060-navi-finserv-limited-2027?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
  
  Repost Cancel
You will now receive notification when someone reply to this message.

+ See More

Broker Research

No Data For Broker Research.

No Data For Block Deals.

*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

03 Dec, 2025

Musigma Securities

Qty 2130379

Price 246.15

% Traded 1.74

03 Dec, 2025

Musigma Securities

Qty 2130379

Price 246.29

% Traded 1.74

03 Dec, 2025

Nk Securities Research Private Limited

Qty 1870248

Price 246.76

% Traded 1.53

03 Dec, 2025

Nk Securities Research Private Limited

Qty 1870248

Price 246.63

% Traded 1.53

03 Dec, 2025

Grt Strategic Ventures Llp

Qty 1206842

Price 246.37

% Traded 0.99

03 Dec, 2025

Grt Strategic Ventures Llp

Qty 1206842

Price 246.25

% Traded 0.99

03 Dec, 2025

Qe Securities Llp

Qty 827611

Price 248.05

% Traded 0.68

03 Dec, 2025

Pace Stock Broking Services Pvt Ltd

Qty 823016

Price 246.35

% Traded 0.67

*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.

+ Show More

Corporate Action

+ See More

Date	Agenda

+ See More

Ex-Date	Type	Dividend (Rs)

+ See More

Announcement Date	Ex-Bonus	Ratio

+ See More

Ex-Split	Old FV	New FV

+ See More

Ex-Right	Ratio	Premium

+ See More

Date	Agenda

+ See More

Financials

Consolidated
Standalone

Quarterly Annually

(Rs. Cr)

Quarterly
Half Yearly
Nine Months
Annual

Detailed Financials

(Rs. Cr)

Revenue

Net Profit

BVPS

Debt to Equity

Quarterly
Half Yearly
Nine Months
Annual

Detailed Financials

Shareholding

Summary

See Top Holdings

Trend

PEERS

Company Name	Price	% Chg	MCap(Cr)	TTM PE	P/B	ROE(%)	1 Yr Perform(%)	Net Profit(Rs.)	Net Sales(Rs.)	Debt to Equity
Hikal	252.89	3.57	3,118.15	308.40	2.47	7.19	-42.71	90	1,859	0.60
Sun Pharma	1,818.30	0.64	436,271.08	41.75	6.04	15.13	1.01	10,980	52,578	0.03
Divis Labs	6,469.00	0.22	171,731.62	69.11	11.47	14.63	3.40	2,191	9,360	0.00
Torrent Pharma	3,795.70	2.01	128,463.74	60.03	17.12	25.17	13.21	1,911	11,516	0.40
Cipla	1,521.00	0.86	122,862.00	22.58	3.94	16.90	1.34	5,291	27,547	0.00

+ See More

About the Company

Hikal Ltd is engaged in R&D, manufacturing and marketing of fine chemicals for the Pharmaceutical and Agrochemical industries.The company collaborates with innovator companies and offer solutions in Contract Research, Custom Synthesis and Custom Manufacturing. The products of the company includes Pharmaceuticals Products: Gabapentin ,Bupropion Hydrochloride ,Gemfibrozil, Pentoxifylline, Ondansetron Hydrochloride , Ondansetron Base, Triprolidine Hydrochloride ,Acebutolol Hydrochloride, Cinnarizine ,Flunarizine Hydrochloride and Levetiracetam.Agrochemicals Products: Diuron ,Ethion ,Isoproturon ,Metoxuron ,Quinalphos and Thiabendazole..The company also in the business segment of Crop Protection, Pharmaceuticals.

Registered Office
- Address
  717/718, Maker Chambers V,,,Nariman Point,
- City
  Mumbai
- State
  Maharashtra
- Pin Code
  400021
- Tel. No.
  022-62770299
- Fax No.
  022-22833913
- Email
  info@hikal.com
- Internet
  http://www.hikal.com
Registrars
- Address
  C 101, 247 Park, L.B.S. Marg, Vikhroli (West),,
- City
  Mumbai 400083
- State
  Maharashtra
- Tel. No.
  022-49186270, 49186200
- Fax No.
  022-49186060
- Email
  rnt.helpdesk@linkintime.co.in
- Internet
  http://www.linkintime.co.in
Management
- Jai Hiremath
  Executive Chairman
- Sameer Hiremath
  Vice Chairman & Mng.Director
- Sarangan Suresh
  Whole Time Director
- Sugandha Hiremath
  Non Executive Director
- Amit Kalyani
  Non Executive Director
+ See More
Included In
- BSE 100
  No
- BSE 200
  No
- SENSEX
  No
- CNX MIDCAP 200
  Yes
- NIFTY 50
  No
- BSE 500
  No
- Nifty 200
  No
Details
- BSE:
  524735
- NSE:
  HIKAL
- Series
  EQ
- ISIN
  INE475B01022